International Clinical Trial: FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855315) titled 'FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps' on Sept. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Services Institute of Medical Sciences, Pakistan

Condition: Chronic Rhinosinusitis (CRS) With Nasal Polyposis

Intervention: Drug: Desmopressin Acetate Nasal, 10 µg/0.1 ml per spray

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 15, 2026

Target Sample Size: 174

To know more, visit https://c...